Pharma Pulse 7/23/24: Post-Roe, How Safe are Period-Tracking Apps? Where to Invest in Health Trends & more

Does Medicare Properly Cover End-of-Life Care for All Beneficiaries?

nvestigators evaluate differences in end-of-life care between Medicare beneficiaries in Medicare Advantage vs. traditional Medicare.

Post-Roe, How Safe Are Period-Tracking Smartphone Apps?

Study investigators surveyed nearly 200 women on their concern around period-tracking apps’ data practices, as well as whether Roe v Wade being overturned influenced their concerns.

The Data That Powers A.I. Is Disappearing Fast

New research from the Data Provenance Initiative has found a dramatic drop in content made available to the collections used to build artificial intelligence.

Where to Invest in Health Trends

Five experts point to investment opportunities related to advancements being made in physical and mental health.

Slope on LinkedIn

“The BMC offers a platform for key players in the clinical trials space to collaborate, share insights, and develop a comprehensive understanding of one another’s challenges.” — Amy Ripston, VP of Marketing at Slope & Executive Director for the Biospecimen Management Consortium (BMC)

Thank you to Pharmaceutical Executive for sharing the news about the launch of the BMC. To learn more about how the consortium will impact today's clinical trial landscape, read below.

#BiospecimenConsortium #BiospecimenManagement #ClinicalTrials

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs